Shared Care Agreements

From 1st October 2023, Broadway Surgery will no longer accept new Shared Care agreements.  This decision has been made jointly with our neighbouring practices in the Wanstead and Woodford Primary Care Networks. We have been receiving a growing number of requests from an increasingly large number of providers.

These requests place an increasing amount of work on our Practice team, and at times, this additional workload is impacting our ability to deliver our core services to you, our patients.

Shared Care Agreements are not a ‘core’ part of our work in General Practice, and without adequate resources to deal with this increasing demand, we can’t continue to assure ourselves that patients are safely monitored to the highest standards of care.

Information for New Patients Taking ADHD Medication

If you are joining Broadway Surgery and currently take medication for ADHD, please note that we are unable to take over shared care prescribing for this treatment. We kindly ask that you continue receiving your ADHD medication through your existing specialist or service.

What this may mean for patients

If there is already a Shared Care Agreement in place for your care, this will continue.

For patients with new treatment plans put in place by Specialists, responsibility for prescribing and monitoring your medication will remain solely with your Specialist. Rather than coming to the Practice for monitoring or reviews, you may be given an outpatient appointment at a hospital or other NHS location.

Examples of medication that may be affected:

DMARD (commonly used for arthritis)

Immunosuppressants

ADHD medications

‘High Risk’ medications

Methotrexate (oral / injection)

Tacrolimus (oral)

Methylphenidate

Amiodarone

Leflunomide

Sirolimus

Dexamfetamine

Dronedarone

Penicillamine

Mycophenolate

Lisdexamfetamine

Riluzole

Sulfasalazine

Ciclosporin (oral)

Atomoxetine

Lithium

Hydroxychloroquine

 

Guanfacine

Valproate (in people of child-bearing potential 12-55y

Azathioprine

   

Midodrine

Mercaptopurine (6-MP)

   

Tolcapone

Page last reviewed: 06 May 2025
Page created: 15 May 2023